Malaria Clinical Trial
Official title:
Clinical Evaluation of Mosquito Coils to Control Malaria in China
Although mosquito coils are widely used, there is no robust evidence that their use can provide clinical reduction in malaria. This study will randomise 4 groups of 400 houses, each with 5 people, in rural China and monitor cases of malaria in each group each month for 6 months. The treatment groups will include Coils, Treated bed nets, Coils plus treated bed nets, or no treatment (control). All cases detected will be given prompt appropriate treatment.
Mosquito coils are extremely widely used by households across the world and reportedly make
up the largest single family expenditure on any health-related items in many developing
Countries. Despite their widespread use there has been no robust clinical evaluation to
determine whether they can provide protection from malaria. This study is designed to
determine if using coils (and / or LLIN) each evening can reduce malaria at the household
level.
The study will be a single-blind, randomised clinical evaluation clustered at the household
level. There will be 4 treatment arms, Coils / Insecticide treated nets / Coils + ITN / No
treatment. Each arm will include 400 households each with 5 people / household (total of
8000 people). A maximum of 20% of houses in any village will be enrolled to reduce any
effects of diversion of mosquitoes by any treatment. Epidemiological factors and baseline
malaria prevalence will be recorded during a pre-intervention baseline month by
questionnaire and rapid diagnostic test (RDT) using species-specific dip sticks for malaria.
Post intervention will be 5 further monthly visits during the malaria season to detect new
cases by RDT, reported fevers and operational data (compliance, adverse effects etc).
Primary outcome clinical measures will be incidence of malaria (P. falciparum / P. vivax)
comparing new cases in each of the 3 treatment & non-treatment groups. All cases will be
treated promptly according to local policy. At the end of the study, all households which
did not have a treated bed net will be provided with one.
Secondary non-clinical outcome measures will include entomological data collected in houses
using / non using coils in sentinel villages at baseline & during the study. CDC mosquito
light traps will be used to record number / species / feeding status / parity (age) /
sporozoite infection rates of mosquitoes in houses using / not-using coils following a
randomised latin square design. Such entomological data can be used to determine reduction
in vector species mosquitoes entering houses using coils and / or ITN.
Ethical approval for the study has been granted by the LSHTM University of London Ethics
Committee and the Yunnan Bureau of Health, P.R.China.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
| Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
| Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
| Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
| Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
| Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
| Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
| Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
| Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
| Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
| Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
| Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
| Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
| Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
| Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
| Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
| Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
| Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
| Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
| Completed |
NCT02315690 -
Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland
|
Phase 3 |